Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2

NCT: NCT05881460 · ACTIVE_NOT_RECRUITING

NCT IDNCT05881460
StatusACTIVE_NOT_RECRUITING
Start Date2023-07-12
Completion2026-11

Brief Summary

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor function in people with Parkinson's disease (PD). vCR will be administered with a device called the Vibrotactile (VT) Touch device. vCR can be used in conjunction with medication and is expected to delay the need to increase dopamine medication. It also provides a more flexible alternative to deep brain stimulation (DBS) in that the vCR therapy can be easily stopped or modified to better suit the patients' needs.

Frequently Asked Questions

What is Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2?

Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2 is a clinical trial registered under NCT05881460. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05881460?

The current status of NCT05881460 (Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2) is: ACTIVE_NOT_RECRUITING.

When did Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2 start?

Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2 started on 2023-07-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑